Citations : Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection

Dated: Sep 24, 2021

Publication Name: ScienceDirect

The development of a safe and effective vaccine is a key requirement to overcoming the COVID-19 pandemic. Recombinant proteins represent the most reliable and safe vaccine approach but generally require a suitable adjuvant for robust and durable immunity. We used the SARS-CoV-2 genomic sequence and in silico structural modelling to design a recombinant spike protein vaccine (Covax-19™).

Read More

Contributors: LeiLia, Yoshikazu Honda-Okubo, Ying Huang, HyesunJang, Michael A. Carlock, Jeremy Baldwin, Sakshi Piplani, Anne G.Bebin-Blackwell, DavidForgacs, Kaori Sakamoto, Alberto Stella, Stuart Turville, Tim Chataway, Alex Colella, Jamie Triccas, Ted M. Ross, Nikolai Petrovsky